Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

Blood

Volumn 121, Issue 22, 2013, Pages 4603-4610

  Fernández Viña, Marcelo A ^a   Klein, John P ^b   Haagenson, Michael ^c   Spellman, Stephen R ^c   Anasetti, Claudio ^d   Noreen, Harriet ^e   Baxter Lowe, Lee Ann ^f   Cano, Pedro ^g   Flomenberg, Neal ^h   Confer, Dennis L ⁱ   Horowitz, Mary M ^b   Oudshoorn, Machteld ^j   Petersdorf, Effie W ^k   Setterholm, Michelle ⁱ   Champlin, Richard ^g   Lee, Stephanie J ^k   De Lima, Marcos ^l  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Statistical Center for International Blood and Marrow Transplant Research   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h THOMAS JEFFERSON UNIVERSITY   (United States)

ⁱ NATIONAL MARROW DONOR PROGRAM   (United States)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k Fred Hutchinson Cancer Research Center   (United States)

^l UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB3 ANTIGEN; HLA DRB4 ANTIGEN; HLA DRB5 ANTIGEN; HLA DR ANTIGEN;

ADULT; ADVERSE OUTCOME; ANTIGEN EXPRESSION; ARTICLE; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; PRIORITY JOURNAL; UNRELATED DONORS; DONOR; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; RISK FACTOR;

ADULT; FEMALE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR BETA-CHAINS; HLA-DRB3 CHAINS; HLA-DRB4 CHAINS; HLA-DRB5 CHAINS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RISK FACTORS; TISSUE DONORS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84880775816     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-481945     Document Type: Article

References (43)

1. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985; 313(13):765-771.
2. Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood. 2012; 119(17):3908-3916.
3. Arora M, Weisdorf DJ, Spellman SR, et al. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol. 2009;27(10): 1644-1652.
4. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104(7): 1923-1930.
5. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13): 4576-4583.
6. Woolfrey A, Klein JP, Haagenson M, et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):885-892.
7. Horan J, Wang T, Haagenson M, et al. Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Blood. 2012;120(14):2918-2924.
8. Spellman SR, Eapen M, Logan BR, et al; National Marrow Donor Program; Center for International Blood and Marrow Transplant Research. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood. 2012;120(2):259-265.
9. Bray RA, Hurley CK, Kamani NR, et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant. 2008; 14(9 Suppl):45-53.
10. Petersdorf EW, Anasetti C, Martin PJ, et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood. 2004;104(9): 2976-2980.
11. Shaw BE, Gooley TA, Malkki M, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007; 110(13):4560-4566.
12. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood. 2004;103(4):1417-1424.
13. Fleischhauer K, Shaw BE, Gooley T, et al; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study [published correction appears in Lancet Oncol. 2012;13(4):e134-5]. Lancet Oncol. 2012;13(4): 366-374.
14. Tosi R, Tanigaki N, Centis D, Ferrara GB, Pressman D. Immunological dissection of human Ia molecules. J Exp Med. 1978;148(6):1592-1611.
15. Nuñez G, Ball EJ, Myers LK, Stastny P. Allostimulating cells in man. Quantitative variation in the expression of HLA-DR and HLA-DQ molecules influences T-cell activation. Immunogenetics. 1985;22(1):85-91.
16. Shackelford DA, Mann DL, van Rood JJ, Ferrara GB, Strominger JL. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci USA. 1981;78(7):4566-4570.
17. Kavathas P, DeMars R, Bach FH, Shaw SSB. SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines. Nature. 1981;293(5835):747-749.
18. Tanigaki N, Tosi R, Duquesnoy RJ, Ferrara GB. Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med. 1983;157(1): 231-247.
19. Long EO, Gorski J, Mach B. Structural relationship of the SB beta-chain gene to HLA-D-region genes and murine I-region genes. Nature. 1984;310(5974):233-235.
20. Nuñez G, Giles RC, Ball EJ, Hurley CK, Capra JD, Stastny P. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations. J Immunol. 1984;133(3): 1300-1306.
21. Trowsdale J, Young JA, Kelly AP, et al. Structure, sequence and polymorphism in the HLA-D region. Immunol Rev. 1985;85:5-43.
22. Wu S, Saunders TL, Bach FH. Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR beta loci. Nature. 1986;324(6098):676-679.
23. Gorski J, Rollini P, Mach B. Structural comparison of the genes of two HLA-DR supertypic groups: the loci encoding DRw52 and DRw53 are not truly allelic. Immunogenetics. 1987;25(6): 397-402.
24. Gorski J, Irle C, Mickelson EM, Sheehy MJ, Termijtelen A, Ucla C, Mach B. Correlation of structure with T cell responses of the three members of the HLA-DRw52 allelic series. J Exp Med. 1989;170(3):1027-1032.
25. Tiercy JM, Gorski J, Bétuel H, Freidel AC, Gebuhrer L, Jeannet M, Mach B. DNA typing of DRw6 subtypes: correlation with DRB1 and DRB3 allelic sequences by hybridization with oligonucleotide probes. Hum Immunol. 1989; 24(1):1-14.
26. Gregersen PK, Shen M, Song QL, et al. Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci USA. 1986;83(8):2642-2646.
27. Bodmer WF. The HLA system. In: Albert ED, Baur MP, Mayr WR, eds. Histocompatibility Testing. Berlin: Springer Verlag; 1984:11-22.
28. WHO Nomenclature Committee. Nomenclature for factors of the HLA system, 1987. Tissue Antigens. 1988;32(4):177-187.
29. Parham P, Lomen CE, Lawlor DA, et al. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci USA. 1988;85(11): 4005-4009.
30. Bodmer JG, Marsh SG, Albert ED, et al. Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens. 1992;39(4): 161-173.
31. Sanchez-Mazas A, Fernandez-Viña M, Middleton D, et al. Immunogenetics as a tool in anthropological studies. Immunology. 2011; 133(2):143-164.
32. Solberg OD, Mack SJ, Lancaster AK, Single RM, Tsai Y, Sanchez-Mazas A, Thomson G. Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum Immunol. 2008;69(7):443-464.
33. Begovich AB, McClure GR, Suraj VC, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol. 1992;148(1):249-258.
34. Kwok WW, Kovats S, Thurtle P, Nepom GT. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation. J Immunol. 1993; 150(6):2263-2272.
35. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4):295-304.
36. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204-217.
37. Gratwohl A, Brand R, Niederwieser D, et al. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. J Clin Oncol. 2011;29(15):1980-1986.
38. Spellman S, Bray R, Rosen-Bronson S, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood. 2010;115(13):2704-2708.
39. Ciurea SO, Thall PF, Wang X, et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood. 2011;118(22): 5957-5964.
40. Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, Fernandez-Viña M. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens. 2003; 62(4):296-307.
41. Hollenbach JA, Madbouly A, Gragert L, et al. A combined DPA1∼DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. Immunogenetics. 2012; 64(8):559-569.
42. Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, Griffioen M, Oudshoorn M, Willemze R, Falkenburg JH. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro. Blood. 2010;115(1):151-153.
43. Rutten CE, van Luxemburg-Heijs SA, Halkes CJ, et al. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease. Biol Blood Marrow Transplant. 2013;19(1):40-48.